One topic. The essentials. A stronger clinical foundation.
19 Oct
DAILY FREE ACCESS
TODAY’S FREE NOTES
FREE
DAY 02 / 60
Myocardial Infarction
Understand the essentials. Connect the clinical cues. Revise with confidence.
Short revision notesDetailed explanationsNCLEX key points
STANCOAST
DAILY PRACTICE
Learn.
Build on it.
Notes, practice and your daily planner.
YOUR NEXT STEP
06
CLINICAL REASONING
03
Think like a nurse.
Recognize cues. Choose priorities.
REASONING IN PRACTICE
04
LEARN · PRACTISE · REVIEW
Know why it matters.
Practise.
Review the why.
Questions with explanations.
HOW WE TEACH
Understand the why.
Clear teaching turns complex topics into ideas you can explain and apply.
Understanding comes first
CLARITY FIRST
02
FROM THE STANCOAST TEAM
Teaching that connects.
Our team makes tough concepts clear and connects each lesson to the decisions a nurse needs to make.
THE NCLEX EDITNO. 02
STANCOAST
THE REVISION JOURNAL
DAILY EDIT
IN THIS ISSUEMyocardial Infarction
Clinical clarity. Lasting confidence.
SHORT NOTES + DEEPER INSIGHTST.
OUR PURPOSE
Prepare with purpose.
We help NCLEX learners build clear understanding, sound clinical judgment and a steady study habit.
A steady path forward
THE STANCOAST APPROACH
01
YOUR DAILY REVISION JOURNAL
8/8 sections explored◷ Next free topic in 17h 3m
THE FULL REVISION PATH
60 days. One place.
All revision notes
Today’s free topic is open. Tap any locked day to explore full-course access.
Free access /
Locked
Days 1–2 include complete notes. Days 3–60 show the planned revision sequence; content is being prepared.
STANCOAST NCLEX COACHING
MI · Revision notes
Quick revision. Full notes. Your next step.
THE REVISION JOURNALTHE NCLEX EDITION
STANCOAST
CLINICAL CLARITY. LASTING CONFIDENCE.
THE CLARITY EDIT
Your next chapter.With clarity.
GUIDED LEARNING FOCUSED REVISIONST.
OPENING NOTES / 01
WELCOME TO YOUR STUDY EDITION
Myocardial infarction
Make space for understanding.
Start with the essentials, connect the ideas, then explore the details at your pace. Your notes stay open while you read.
INSIDE THIS EDITION
01—04 Foundations & clinical cues
05—08 Care, nursing & NCLEX review
Switch between short and detailed notes anytime.
STANCOAST JOURNAL
01
Detailed notes · Definition8 / 8 sections opened
Swipe for all sections →
FULL DETAILED NOTES
01 / 08 · Definition
Definition
Connect the blood-flow problem to the patient’s symptoms and the urgency of care.
01What actually happens?
The myocardium is the heart muscle. Coronary arteries deliver the oxygen-rich blood it needs to contract.
Ischemia means inadequate oxygen delivery. If severe ischemia persists, myocardial cells die: this is infarction. Restoring flow can save threatened tissue; it cannot revive tissue that has already died.
The size and location of injury influence pumping function, electrical stability, and the risk of complications.
02MI, angina, and cardiac arrest
Stable angina is transient ischemic discomfort, often with exertion, without acute myocardial necrosis. A new or worsening pattern needs urgent reassessment.
Acute coronary syndrome (ACS) includes unstable angina, NSTEMI, and STEMI. Unstable angina does not have the biomarker evidence of necrosis that defines MI.
Cardiac arrest means there is no effective circulation. An MI patient may still be awake with a pulse; an MI can nevertheless cause a fatal dysrhythmia and arrest.
03STEMI and NSTEMI
STEMI is an emergency presentation with qualifying ST elevation or an equivalent pattern that triggers immediate reperfusion evaluation.
NSTEMI has acute ischemic myocardial injury without persistent qualifying ST elevation. It can still be large, unstable, and life-threatening.
Do not use “complete versus partial blockage” as an absolute rule. ECG patterns do not perfectly describe coronary anatomy.
NCLEX CONNECTION
A patient is alert and talking during an MI.
Nursing reasoning
This does not make the situation safe. A pulse rules out current cardiac arrest, not an evolving MI. Continue urgent ACS assessment and monitoring.
Separate the immediate cause of infarction from the factors that made it more likely.
01The common pathway: plaque and thrombosis
Atherosclerotic plaque develops in a coronary artery over time. Plaque contains lipid and inflammatory material beneath a protective surface.
Rupture or erosion exposes material that activates platelets and coagulation. A thrombus forms and may sharply reduce coronary flow.
The consequence is an oxygen shortage in the supplied muscle. Without rapid correction, ischemia progresses to necrosis.
02Other coronary causes
Coronary spasm can severely constrict an artery. Smoking and stimulants such as cocaine can contribute.
An embolus can travel into a coronary artery and obstruct it.
Spontaneous coronary artery dissection separates layers of the artery wall and can impair flow. It can occur without the usual atherosclerotic risk profile.
03Oxygen supply–demand mismatch
Severe anemia or hypoxemia reduces oxygen availability; hypotension can reduce coronary perfusion.
A sustained rapid heart rate increases demand and shortens filling time. Severe illness may produce several stresses at once.
Mismatch can cause MI when there is acute injury plus evidence of ischemia. A troponin elevation during illness alone does not establish MI.
04Risk factors to recognize
Modifiable risks include smoking, hypertension, abnormal lipids, diabetes, inactivity, and obesity. Prevention addresses these over time.
Increasing age and a family history of premature coronary disease increase risk but cannot be changed.
Risks help interpret the presentation. Their absence does not exclude MI, and their presence does not confirm it.
05Link the cause to care
Plaque-associated ACS often needs antithrombotic therapy and evaluation for revascularization.
A supply–demand problem also requires correction of the trigger, such as severe hypoxemia, bleeding, or a tachyarrhythmia.
Different mechanisms need different treatment plans. Do not assume every elevated troponin requires fibrinolysis.
NCLEX CONNECTION
A patient with major blood loss develops tachycardia and ischemic changes.
Nursing reasoning
Reduced oxygen-carrying capacity and increased demand may contribute to ischemic injury. Escalate the deterioration and address the cause with the treating team.
Read the whole presentation, then compare changes over time.
01Typical discomfort
Central pressure, squeezing, heaviness, or fullness may persist or recur. The patient may describe discomfort rather than sharp pain.
Discomfort can extend to either arm, shoulders, neck, jaw, back, or upper abdomen.
Ask when it began, its duration, severity, location, radiation, and associated symptoms. Record the symptom-onset time.
02Associated symptoms
Dyspnea can occur with or without chest discomfort. Cold sweating, nausea, lightheadedness, and unusual fatigue are important cues.
Palpitations or a rapid or irregular heartbeat can accompany the event.
Do not dismiss a cluster of symptoms as indigestion or anxiety before evaluating a possible cardiac cause.
03Less obvious presentations
Some patients have little or no chest pain. Older adults and people with diabetes deserve particular attention to unexplained breathlessness, weakness, or deterioration.
Chest discomfort remains common in women. Women may also report nausea, back or shoulder discomfort, or unusual fatigue.
Symptoms can begin mildly. Neither mild discomfort nor temporary symptom improvement reliably excludes ACS.
04Look for instability
Hypotension, cool clammy skin, altered mentation, or reduced urine output can indicate poor tissue perfusion.
New crackles, worsening oxygenation, and respiratory distress can indicate acute heart failure.
A sustained dysrhythmia, syncope, or new severe deterioration needs immediate escalation, not routine follow-up.
05The response to suspected MI
In the community, activate emergency medical services rather than driving to the hospital.
In a care setting, assess immediate stability and activate the ACS/emergency pathway. Obtain prompt ECG evaluation and monitoring.
Pain characteristics and response to nitroglycerin cannot independently confirm or rule out MI.
NCLEX CONNECTION
An older patient reports new breathlessness and weakness but denies chest pain.
Nursing reasoning
The absence of chest pain does not exclude MI. Assess stability and seek prompt evaluation of possible ACS and other serious causes.
Symptoms, ECG findings, serial biomarkers, and imaging answer different questions.
01Prompt 12-lead ECG
For suspected ACS, obtain and interpret a 12-lead ECG within 10 minutes of first medical contact.
An initially nondiagnostic ECG does not end the evaluation. Repeat ECGs when symptoms persist or the condition changes.
ST depression, T-wave changes, or a normal tracing may occur in NSTEMI. Additional leads may be needed for suspected posterior or right-ventricular involvement.
02High-sensitivity troponin
Troponin detects myocardial injury. Interpret results against the assay’s sex-specific 99th-percentile upper reference limit and the local serial-testing pathway.
A changing troponin pattern helps identify acute injury. MI requires evidence that the injury is ischemic, rather than an isolated abnormal value.
Other conditions, including heart failure, myocarditis, and severe systemic illness, may elevate troponin. Interpret the patient and the trend together.
03What the patterns mean
STEMI or a qualifying equivalent demands urgent reperfusion evaluation. Do not wait for a troponin result to activate a clear STEMI pathway.
NSTEMI requires biomarker evidence of acute ischemic injury without persistent qualifying ST elevation.
An early normal biomarker or ECG alone is not sufficient to exclude MI. Follow the validated evaluation pathway.
04Imaging and other investigations
Echocardiography assesses ventricular function and may show regional wall-motion abnormalities or mechanical complications.
Coronary angiography identifies coronary anatomy and can allow PCI during the same procedure.
CBC, renal function, electrolytes, and other ordered tests guide treatment safety. Chest imaging may assess complications or alternative causes; it does not independently diagnose MI.
05Avoid diagnostic delays
Collect focused history, medications, allergies, recent bleeding, and onset time while urgent assessment proceeds.
Report a change in symptoms, perfusion, or rhythm promptly. Do not assume that a previously reassuring test remains reassuring after deterioration.
Stable patients may undergo further risk assessment after acute MI is excluded. Exercise stress testing is not the immediate test for an unstable suspected MI.
NCLEX CONNECTION
The first ECG is nondiagnostic, but chest pressure continues.
Nursing reasoning
Continue the ACS evaluation with serial ECGs and ordered biomarkers. A single early test cannot safely settle the diagnosis.
Treatment depends on the ECG pathway, patient stability, bleeding risk, timing, and coronary anatomy. Learn each class by what it does, what can harm the patient, and what the nurse must reassess.
01Primary PCI for STEMI
Percutaneous coronary intervention uses a catheter to open a culprit coronary artery, usually with balloon treatment and a stent.
Primary PCI is the preferred reperfusion method when it can be delivered promptly. Activate the catheterization team and prepare transfer if needed.
System timing goals differ for direct presentation and transfer. Use the local STEMI pathway rather than delaying while completing nonessential tasks.
02When fibrinolysis is considered
A fibrinolytic dissolves fibrin in a clot. It is an option for selected STEMI patients when timely PCI is unavailable.
Eligibility depends on onset time, ECG findings, and a formal contraindication screen. Active bleeding, prior intracranial hemorrhage, and severe uncontrolled hypertension are major safety concerns.
After fibrinolysis, the patient still needs a PCI-capable care pathway. Persistent ischemia or failed reperfusion may require rescue PCI.
03NSTEMI management
Antiplatelet and anticoagulant therapy are used as prescribed, alongside management of symptoms and complications.
Invasive evaluation is guided by risk and stability. Recurrent ischemia, shock, or dangerous dysrhythmia can make evaluation urgent.
Fibrinolysis is not used for NSTEMI. A positive troponin alone is not an indication for a clot-busting drug.
04When CABG may be chosen
Coronary artery bypass grafting routes blood around diseased coronary segments using graft vessels.
The team may choose CABG for selected anatomy or when PCI is unsuitable. Coronary complexity and comorbidities affect the decision.
Preparation and antithrombotic planning depend on the operation and urgency; do not independently stop prescribed therapy.
05Oxygen and symptom control
For ACS with oxygen saturation below 90%, administer and titrate oxygen per protocol. Routine oxygen is not recommended for a normally oxygenated patient without another indication.
Treat ischemic discomfort with prescribed therapy after checking safety. Reassess blood pressure and symptoms after treatment.
“MONA” is a historical mnemonic, not an order of treatment. It must not delay ECG assessment or reperfusion.
06Antiplatelets: aspirin and a P2Y12 inhibitor
Aspirin and agents such as clopidogrel or ticagrelor reduce platelet activation/aggregation. They prevent thrombotic events; they do not dissolve an existing clot.
Check allergy, bleeding history, and concurrent medicines. Monitor abnormal bruising, melena, hematuria, and other bleeding cues.
Teach patients not to stop post-stent therapy on their own. Prasugrel is contraindicated with a history of stroke or TIA.
07Anticoagulants: heparin and related agents
Anticoagulants limit clot formation and extension through the coagulation pathway. Agent choice depends on the ACS treatment plan and kidney function.
For IV unfractionated heparin, monitor the ordered aPTT or anti-Xa target, CBC, and platelets. Do not apply the UFH aPTT rule to every anticoagulant.
A marked platelet fall or new thrombosis may signal HIT. Hold/stop heparin according to the urgent protocol and notify the treating team; HIT can cause thrombosis, not just bleeding.
08Nitrates: nitroglycerin
Vasodilation reduces cardiac workload and can relieve ischemic discomfort. Nitroglycerin is not a fibrinolytic.
Check blood pressure, suspected right-ventricular infarction, and recent PDE5-inhibitor use before administration. Nitrates with these medicines can cause dangerous hypotension.
Sublingual medication is placed under the tongue, not swallowed. Reassess pain and pressure; persistent or recurrent symptoms need urgent evaluation.
09Beta blockers: metoprolol
Slowing heart rate and reducing contractility can lower myocardial oxygen demand in appropriate, stable patients.
Check heart rate, blood pressure, conduction abnormalities, and heart failure/shock risk. Severe bradycardia, significant AV block, acute decompensated HF, or shock can make administration unsafe.
Use prescribed hold parameters and escalate unsafe findings. Do not invent a universal pulse threshold or abruptly stop chronic treatment without advice.
10Statins: atorvastatin or rosuvastatin
High-intensity statins lower LDL and reduce future cardiovascular events. Their role extends beyond treatment of a single current symptom.
Report unexplained muscle pain, weakness, or dark urine because severe muscle injury can damage the kidneys.
Review interactions and the follow-up lipid plan. Atorvastatin can be taken at any time of day; “every statin must be taken at night” is incorrect.
11ACE inhibitors / ARBs
Agents such as lisinopril or valsartan may support blood-pressure control and ventricular function when indicated.
Monitor blood pressure, potassium, and renal function. Potassium supplements and potassium-containing salt substitutes may increase hyperkalemia risk.
ACE inhibitors may cause a dry cough. Lip, tongue, or throat swelling suggests angioedema: stop the drug and obtain emergency airway assessment.
12Fibrinolytics: tenecteplase or alteplase
These drugs promote fibrin breakdown in selected eligible STEMI patients when appropriate PCI access is delayed.
Complete the contraindication checklist and baseline neurologic assessment. Monitor closely for bleeding and avoid unnecessary punctures or intramuscular injections.
New severe headache, focal weakness, reduced consciousness, or another neurologic change may indicate intracranial bleeding and needs emergency escalation.
13Opioids and other supportive drugs
Morphine may be used for selected refractory pain. It is not a routine first step for every suspected MI.
Monitor sedation, respiratory rate, oxygenation, and blood pressure. Opioids can delay absorption of oral P2Y12 inhibitors.
Diuretics may be prescribed for congestion; monitor urine output, renal function, and electrolytes. Drug choice follows the complication, not a fixed universal MI list.
NCLEX CONNECTION
Chest pain decreases after nitroglycerin, but a STEMI pattern remains.
Nursing reasoning
Continue urgent reperfusion care. Symptom relief does not mean that the coronary thrombus has resolved.
Reperfusion is one part of care. The team also protects circulation, detects complications, and prevents recurrence.
01Watch for complications
Rhythm disturbances may reduce cardiac output or cause arrest. Evaluate the patient, not just the monitor tracing.
Acute heart failure and cardiogenic shock require urgent multidisciplinary management. Watch respiratory status, perfusion, and urine output.
Sudden hypotension, new murmur, or rapid respiratory deterioration can signal a mechanical complication and need urgent evaluation.
02Secondary prevention
Prescribed antiplatelet therapy reduces further thrombotic events. Duration is individualized; the default ACS strategy is at least 12 months of dual antiplatelet therapy when bleeding risk is not high.
High-intensity statin treatment and control of blood pressure, diabetes, and smoking risk are central to prevention.
Other medicines depend on ventricular function, blood pressure, renal function, and the patient’s indications. Not every MI patient receives every drug class.
03Recovery plan
Cardiac rehabilitation combines supervised activity, education, and support. Recovery activity is increased according to the care plan.
Arrange follow-up, medication reconciliation, and clear teaching about recurrent symptoms.
Address fear, anxiety, depression, and practical barriers to treatment. Recovery depends on support as well as prescriptions.
NCLEX CONNECTION
A stable patient with suspected ACS has SpO₂ 97% on room air.
Nursing reasoning
Do not give oxygen automatically solely because MI is suspected. Continue assessment and the ACS pathway; administer oxygen for hypoxemia or another indication.
Prioritize instability, anticipate complications, and evaluate the response to every intervention.
01Why the nurse acts quickly
Delay can increase irreversible muscle loss. Obtain the ECG and activate the ACS pathway promptly.
Recognize impaired perfusion, acute heart failure, and dangerous rhythm changes while the team prepares definitive treatment.
The 2026 universal definition groups MI as primary, secondary, or procedure-related. Older learning resources use numerical types; understand the mechanism rather than memorizing a label alone.
02Check whether treatment is working
Reassess symptoms, ECG/rhythm, blood pressure, oxygenation, and perfusion. Improvement in pain alone does not prove that flow is restored.
Watch for recurrent ischemia, bleeding, heart failure, and dysrhythmia.
Document interventions and response. New deterioration requires immediate reassessment of complications or failed treatment.
03Immediate stabilization
Assess airway, breathing, circulation, mental status, and pain. Activate the appropriate emergency response for instability.
Use continuous rhythm monitoring, obtain IV access, and collect ordered tests while the ACS pathway proceeds.
Review allergies, medications, bleeding history, and contraindications before administering prescribed therapies.
04Assess and act in parallel
Check immediate ABCs, vital signs, oxygenation, pain, and perfusion. Activate help for deterioration while obtaining focused information.
Record symptom-onset time and facilitate the 12-lead ECG, monitoring, IV access, and ordered treatment.
For pulseless unresponsiveness, activate the resuscitation pathway and start CPR. Use the defibrillator/AED according to the rhythm and resuscitation protocol.
05Recognize patterns of deterioration
New hypotension, confusion, cool skin, or oliguria suggests reduced perfusion; worsening dyspnea and crackles suggest heart failure.
A new murmur with hypotension or pulmonary edema after MI can indicate papillary muscle or septal rupture. Escalate immediately for urgent evaluation.
Recurrent chest discomfort or ischemic changes can indicate reinfarction or ongoing ischemia. Do not label a new episode as routine post-procedure pain.
06Medication safety and reassessment
Check allergies, bleeding cues, blood pressure, pulse, renal function, and drug interactions relevant to the ordered medication.
Reassess the intended effect and adverse effects after administration. Document symptoms, vital trends, treatment, and response.
Escalate abnormal findings with a focused report: what changed, when, current vitals/rhythm, recent treatments, and immediate concerns.
07Care after PCI
Inspect the access site for bleeding and an expanding hematoma. Compare distal pulse, warmth, color, sensation, and movement.
Follow access-specific positioning and movement instructions. Radial and femoral procedures do not have identical precautions.
Hypotension with new back or flank pain after femoral access can suggest concealed bleeding. Escalate even if the visible puncture site looks clean.
08Discharge and teach-back
Ask the patient to explain the purpose of each medicine, how to take it, and which effects require help. Reinforce antiplatelet adherence.
Teach the emergency response to recurrent heart-attack symptoms: activate EMS promptly rather than driving or waiting to see if symptoms settle.
Confirm cardiac rehab, follow-up, smoking cessation support, and a realistic activity plan. Include family/support persons with the patient’s consent.
09Evaluate outcomes
Improved pain, stable circulation, appropriate oxygenation, and absence of recurrent ischemia or bleeding are useful response indicators.
A patient’s ability to explain the care plan is more useful than simply documenting that instructions were provided.
Progress in this revision section measures topics opened. It is not a score of clinical competence or a substitute for supervised practice.
NCLEX CONNECTION
Following femoral PCI, a patient becomes hypotensive and reports back pain.
Nursing reasoning
Suspect concealed bleeding and urgently reassess/escalate. A dry visible access site does not exclude a serious internal complication.
Review the key reminder and clinical reasoning from every part of this disorder. Use any section in any order.
01What is MI? — key point & reasoning
MI can trigger arrest. Chest pain alone does not diagnose MI.
A patient is alert and talking during an MI.
This does not make the situation safe. A pulse rules out current cardiac arrest, not an evolving MI. Continue urgent ACS assessment and monitoring.
02Causes & risks — key point & reasoning
A risk factor is a clue—not confirmation of MI.
A patient with major blood loss develops tachycardia and ischemic changes.
Reduced oxygen-carrying capacity and increased demand may contribute to ischemic injury. Escalate the deterioration and address the cause with the treating team.
03Signs & symptoms — key point & reasoning
Women commonly have chest discomfort too. No classic pain ≠ no MI.
An older patient reports new breathlessness and weakness but denies chest pain.
The absence of chest pain does not exclude MI. Assess stability and seek prompt evaluation of possible ACS and other serious causes.
04Diagnosis — key point & reasoning
One early normal test does not exclude MI. Do not wait for troponin before STEMI reperfusion.
The first ECG is nondiagnostic, but chest pressure continues.
Continue the ACS evaluation with serial ECGs and ordered biomarkers. A single early test cannot safely settle the diagnosis.
05Treatment — key point & reasoning
No fibrinolysis for NSTEMI. Pain relief ≠ restored coronary flow.
Chest pain decreases after nitroglycerin, but a STEMI pattern remains.
Continue urgent reperfusion care. Symptom relief does not mean that the coronary thrombus has resolved.
06Medical care — key point & reasoning
“MONA” is not a treatment order. Do not delay reperfusion.
A stable patient with suspected ACS has SpO₂ 97% on room air.
Do not give oxygen automatically solely because MI is suspected. Continue assessment and the ACS pathway; administer oxygen for hypoxemia or another indication.
07Pharmacology — key point & reasoning
Antiplatelet ≠ anticoagulant ≠ fibrinolytic. Nitroglycerin does not dissolve a clot.
A patient prescribed nitroglycerin reports recent sildenafil use.
Pause administration and notify the prescriber. The combination can produce severe hypotension; use the protocol to determine a safe alternative.
08Nursing role — key point & reasoning
New murmur + hypotension after MI → suspect a mechanical complication; urgent escalation.
Following femoral PCI, a patient becomes hypotensive and reports back pain.
Suspect concealed bleeding and urgently reassess/escalate. A dry visible access site does not exclude a serious internal complication.
NCLEX CONNECTION
A patient prescribed nitroglycerin reports recent sildenafil use.
Nursing reasoning
Pause administration and notify the prescriber. The combination can produce severe hypotension; use the protocol to determine a safe alternative.
DAILY
